Literature DB >> 25305314

4-1BB ligand activates bystander dendritic cells to enhance immunization in trans.

Douglas C Macdonald1, Alastair Hotblack1, Saniath Akbar1, Gary Britton1, Mary K Collins2, William C Rosenberg3.   

Abstract

Expression of the costimulatory receptor 4-1BB is induced by TCR recognition of Ag, whereas 4-1BB ligand (4-1BBL) is highly expressed on activated APC. 4-1BB signaling is particularly important for survival of activated and memory CD8(+) T cells. We wished to test whether coexpression of Ag and 4-1BBL by dendritic cells (DC) would be an effective vaccine strategy. Therefore, we constructed lentiviral vectors (LV) coexpressing 4-1BBL and influenza nucleoprotein (NP). Following s.c. immunization of mice, which targets DC, we found superior CD8(+) T cell responses against NP and protection from influenza when 4-1BBL was expressed. However, functionally superior CD8(+) T cell responses were obtained when two LV were coinjected: one expressing 4-1BBL and the other expressing NP. This surprising result suggested that 4-1BBL is more effective when expressed in trans, acting on adjacent DC. Therefore, we investigated the effect of LV expression of 4-1BBL in mouse DC cultures and observed induced maturation of bystander, untransduced cells. Maturation was blocked by anti-4-1BBL Ab, required cell-cell contact, and did not require the cytoplasmic signaling domain of 4-1BBL. Greater maturation of untransduced cells could be explained by LV expression of 4-1BBL, causing downregulation of 4-1BB. These data suggest that coexpression of 4-1BBL and Ag by vaccine vectors that target DC may not be an optimal strategy. However, 4-1BBL LV immunization activates significant numbers of bystander DC in the draining lymph nodes. Therefore, transactivation by 4-1BBL/4-1BB interaction following DC-DC contact may play a role in the immune response to infection or vaccination.
Copyright © 2014 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25305314      PMCID: PMC4255227          DOI: 10.4049/jimmunol.1301723

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  41 in total

1.  Expression and costimulatory effects of the TNF receptor superfamily members CD134 (OX40) and CD137 (4-1BB), and their role in the generation of anti-tumor immune responses.

Authors:  Vadim Y Taraban; Tania F Rowley; Lyn O'Brien; H T Claude Chan; Linsey E Haswell; Michael H A Green; Alison L Tutt; Martin J Glennie; Aymen Al-Shamkhani
Journal:  Eur J Immunol       Date:  2002-12       Impact factor: 5.532

2.  4-1BBL cooperates with B7-1 and B7-2 in converting a B cell lymphoma cell line into a long-lasting antitumor vaccine.

Authors:  B A Guinn; M A DeBenedette; T H Watts; N L Berinstein
Journal:  J Immunol       Date:  1999-04-15       Impact factor: 5.422

3.  Skin-derived dendritic cells induce potent CD8(+) T cell immunity in recombinant lentivector-mediated genetic immunization.

Authors:  Yukai He; Jiying Zhang; Cara Donahue; Louis D Falo
Journal:  Immunity       Date:  2006-05       Impact factor: 31.745

4.  The adjuvant effects of co-stimulatory molecules on cellular and memory responses to HBsAg DNA vaccination.

Authors:  Xiaogang Du; Guoxing Zheng; Huali Jin; Youmin Kang; Junpeng Wang; Chong Xiao; Shuo Zhang; Lin Zhao; Aoshuang Chen; Bin Wang
Journal:  J Gene Med       Date:  2007-02       Impact factor: 4.565

5.  A casein kinase I motif present in the cytoplasmic domain of members of the tumour necrosis factor ligand family is implicated in 'reverse signalling'.

Authors:  A D Watts; N H Hunt; Y Wanigasekara; G Bloomfield; D Wallach; B D Roufogalis; G Chaudhri
Journal:  EMBO J       Date:  1999-04-15       Impact factor: 11.598

6.  Enhancement of HIV-specific CD8 T cell responses by dual costimulation with CD80 and CD137L.

Authors:  Jacob Bukczynski; Tao Wen; Chao Wang; Natasha Christie; Jean-Pierre Routy; Mohamed-Rachid Boulassel; Colin M Kovacs; Kelly S Macdonald; Mario Ostrowski; Rafick-Pierre Sekaly; Nicole F Bernard; Tania H Watts
Journal:  J Immunol       Date:  2005-11-15       Impact factor: 5.422

7.  Immune responses in 4-1BB (CD137)-deficient mice.

Authors:  Byoung S Kwon; Jose C Hurtado; Zang H Lee; Kyu B Kwack; Su K Seo; Beom K Choi; Beverly H Koller; Godwin Wolisi; Hal E Broxmeyer; Dass S Vinay
Journal:  J Immunol       Date:  2002-06-01       Impact factor: 5.422

8.  4-1BB-specific monoclonal antibody promotes the generation of tumor-specific immune responses by direct activation of CD8 T cells in a CD40-dependent manner.

Authors:  Robert E Miller; Jon Jones; Tiep Le; James Whitmore; Norman Boiani; Brian Gliniak; David H Lynch
Journal:  J Immunol       Date:  2002-08-15       Impact factor: 5.422

9.  Lentiviral vectors transduce proliferating dendritic cell precursors leading to persistent antigen presentation and immunization.

Authors:  Frederick Arce; Helen M Rowe; Benjamin Chain; Luciene Lopes; Mary K Collins
Journal:  Mol Ther       Date:  2009-07-07       Impact factor: 11.454

10.  Conventional dendritic cells are required for the activation of helper-dependent CD8 T cell responses to a model antigen after cutaneous vaccination with lentiviral vectors.

Authors:  Hugh D Goold; David Escors; Thomas J Conlan; Ronjon Chakraverty; Clare L Bennett
Journal:  J Immunol       Date:  2011-03-09       Impact factor: 5.422

View more
  4 in total

1.  Local Treatment of a Pediatric Osteosarcoma Model with a 4-1BBL Armed Oncolytic Adenovirus Results in an Antitumor Effect and Leads to Immune Memory.

Authors:  Naiara Martinez-Velez; Virginia Laspidea; Marta Zalacain; Ana Patiño-García; Marta M Alonso; Sara Labiano; Marc García-Moure; Montse Puigdelloses; Lucía Marrodan; Marisol Gonzalez-Huarriz; Guillermo Herrador; Daniel de la Nava; Iker Ausejo-Mauleon; Juan Fueyo; Candelaria Gomez-Manzano
Journal:  Mol Cancer Ther       Date:  2022-03-01       Impact factor: 6.261

2.  CD137 Stimulation Enhances Cetuximab-Induced Natural Killer: Dendritic Cell Priming of Antitumor T-Cell Immunity in Patients with Head and Neck Cancer.

Authors:  Raghvendra M Srivastava; Sumita Trivedi; Fernando Concha-Benavente; Sandra P Gibson; Carly Reeder; Soldano Ferrone; Robert L Ferris
Journal:  Clin Cancer Res       Date:  2016-08-05       Impact factor: 12.531

3.  A Distinct Transcriptional Program in Human CAR T Cells Bearing the 4-1BB Signaling Domain Revealed by scRNA-Seq.

Authors:  Angela C Boroughs; Rebecca C Larson; Nemanja D Marjanovic; Kirk Gosik; Ana P Castano; Caroline B M Porter; Selena J Lorrey; Orr Ashenberg; Livnat Jerby; Matan Hofree; Gabriela Smith-Rosario; Robert Morris; Joshua Gould; Lauren S Riley; Trisha R Berger; Samantha J Riesenfeld; Orit Rozenblatt-Rosen; Bryan D Choi; Aviv Regev; Marcela V Maus
Journal:  Mol Ther       Date:  2020-07-25       Impact factor: 11.454

Review 4.  Reconstructing the immune system with lentiviral vectors.

Authors:  Henning Olbrich; Constanze Slabik; Renata Stripecke
Journal:  Virus Genes       Date:  2017-07-25       Impact factor: 2.332

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.